MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2021.790834

Медицинская библиотека · Frontiers in pharmacology · 2022

Different Monoclonal Antibodies in Myasthenia Gravis: A Bayesian Network Meta-Analysis.

Song Zhaoming, Zhang Jie, Meng Jiahao, Jiang Guannan, Yan Zeya, Yang Yanbo, Chen Zhouqing, You Wanchun, Wang Zhong, Chen Gang

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Background

Myasthenia gravis (MG) is a common autoimmune disease with acquired neuromuscular transmission disorders. Recently, monoclonal antibodies have been shown to successfully treat a variety of diseases.

Methods

In this meta-analysis, an appropriate search strategy was used to search eligible randomized controlled trials (RCTs) on different monoclonal antibodies to treat patients with MG published up to September 2021 from the embase, PubMed, and Cochrane Library. We assessed the average difference or odds ratio between each drug and placebo and summarized them as the average and 95% confidence interval (CI), respectively.

Results

In indicators of efficacy, patients receiving eculizumab (MD, -1.9; 95% CI, -3.2-0.76) had decreases in MG-ADL scores compared to placebo. In addition, only eculizumab (MD, -3.1; 95% CI, -4.7-1.5) and efgartigimod (MD, -1.4; 95% CI, -2.1-0.68) showed a significant difference from placebo in the amount of reduction in QMG scores, while neither of the other two monoclonal antibodies was statistically significant. With regard to the safety of monoclonal antibody therapy, there was no significant difference in the probability of AE in subjects treated with any of the four monoclonal antibodies compared to placebo.

Conclusions

eculizumab was effective in reducing MG-ADL scores and QMG scores in myasthenia gravis. Meanwhile, eculizumab also caused fewer AE. As an emerging therapy, monoclonal antibodies are prospective in the treatment of MG. However, more researches are required to be invested in the future as the results obtained from small sample sizes are not reliable enough.

Для цитирования: Song Zhaoming, Zhang Jie, Meng Jiahao, Jiang Guannan, Yan Zeya, Yang Yanbo, Chen Zhouqing, You Wanchun, Wang Zhong, Chen Gang. Different Monoclonal Antibodies in Myasthenia Gravis: A Bayesian Network Meta-Analysis.. Frontiers in pharmacology. 2022. DOI: 10.3389/fphar.2021.790834.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.